Suchergebnisse - "Kondo, Yasuteru"

PubPharm (162)

1

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma : TACTICS-L Trial

enthalten in: Liver cancer | 2024

von Kudo, M. | Ueshima, K. | Saeki, I. | +23

2

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice : An Observational Post-Marketing Study in Japan

enthalten in: Drugs - real world outcomes | 2023

von Furuse, J. | Izumi, N. | Motomura, K. | +6

3

Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma

enthalten in: Cancers | 2023

von Tokunaga, T. | Tateyama, M. | Kondo, Y. | +13

4

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

enthalten in: Drugs - real world outcomes | 2023

von Furuse, J. | Izumi, N. | Motomura, K. | +6

5

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

enthalten in: Drugs - real world outcomes | 2023

von Furuse, J. | Izumi, N. | Motomura, K. | +6

6

Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan

enthalten in: Drugs - real world outcomes | 2023

von Furuse, J. | Izumi, N. | Motomura, K. | +6

7

DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC

enthalten in: Scientific reports | 2022

von Kondo, Y. | Morosawa, T. | Minami, S. | +1

8

Clinical practice guidelines for autoimmune hepatitis

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Ohira, H. | Takahashi, A. | Zeniya, M. | +17

ErratumIn: Hepatol Res. 2022 Oct;52(10):894. - PMID 35839143

9

Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy : A Multicenter Retrospective Study

enthalten in: Journal of clinical medicine | 2022

von Kawaratani, H. | Kondo, Y. | Tatsumi, R. | +20

10

Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment

enthalten in: Scientific reports | 2022

von Kondo, Y. | Akahira, J. | Morosawa, T. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]